Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder

Primary Cutaneous Acral CD8-Positive T-Cell Lymphoproliferative Disorder — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05978141	A Registry for People With T-cell Lymphoma	recruiting	—	1,000	Memorial Sloan Kettering Cancer CenterOTHER	1	May 20, 2026	clinicaltrials
NCT06716658	JAK1 Inhibitor Golidocitnib for the Treatment of Relapsed/Refractory Indolent T/NK-cell Lymphomas	recruiting	Phase 2	48	Institute of Hematology & Blood Diseases Hospital, ChinaOTHER	1	Nov 18, 2025	clinicaltrials

Data updated 22 days agoSource updated May 20, 2026source: clinicaltrials